| Dr John G King, MD | |
|
28 Centre Dr, Milton, VT 05468-3104 | |
| (802) 847-4322 | |
| Not Available |
| Full Name | Dr John G King |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 28 Centre Dr, Milton, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811910540 | NPI | - | NPPES |
| 01071205 | Medicaid | VT | |
| 1010264 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 420010681 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Champlain Valley Physicians Hospital Medical Ctr | Plattsburgh, NY | Hospital |
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
| Central Vermont Medical Center Inc | 9335138817 | 204 |
| Champlain Valley Physicians Hospital Medical Center | 2769396878 | 233 |
News Archive
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system.
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol.
› Verified 3 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system.
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol.
› Verified 3 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system.
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol.
› Verified 3 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system.
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John G King, MD 28 Centre Dr, Milton, VT 05468-3104 Ph: (802) 847-4322 | Dr John G King, MD 28 Centre Dr, Milton, VT 05468-3104 Ph: (802) 847-4322 |
News Archive
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system.
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol.
› Verified 3 days ago
Dr. John J Saia, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 | |
Dr. John P Fogarty, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 | |
Dr. John C Ferguson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 | |
Dr. David N Little, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 | |
Dr. Monica C Romanko, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 Fax: 802-847-1570 | |
Laura Beth Chamberlain, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Centre Dr, Milton, VT 05468 Phone: 802-847-4322 | |
Michelle Dianne Dorwart, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Centre Dr, Milton Family Practice- 416sa1, Milton, VT 05468 Phone: 802-847-2700 |